Modified-Release Hydrocortisone in Congenital Adrenal Hyperplasia

CONTEXT: Standard glucocorticoid therapy in congenital adrenal hyperplasia (CAH) regularly fails to control androgen excess, causing glucocorticoid overexposure and poor health outcomes. OBJECTIVE: We investigated whether modified-release hydrocortisone (MR-HC), which mimics physiologic cortisol sec...

Descripción completa

Detalles Bibliográficos
Autores principales: Merke, Deborah P, Mallappa, Ashwini, Arlt, Wiebke, Brac de la Perriere, Aude, Lindén Hirschberg, Angelica, Juul, Anders, Newell-Price, John, Perry, Colin G, Prete, Alessandro, Rees, D Aled, Reisch, Nicole, Stikkelbroeck, Nike, Touraine, Philippe, Maltby, Kerry, Treasure, F Peter, Porter, John, Ross, Richard J
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Oxford University Press 2021
Materias:
Clinical Research Articles
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8063257/
https://www.ncbi.nlm.nih.gov/pubmed/33527139
http://dx.doi.org/10.1210/clinem/dgab051

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8063257/
https://www.ncbi.nlm.nih.gov/pubmed/33527139
http://dx.doi.org/10.1210/clinem/dgab051

Ejemplares similares